From: Targetable alterations in invasive pleomorphic lobular carcinoma of the breast
Age | Â | Tumor | Â | Node | Â | Stage | Â | Receptor status | Â |
---|---|---|---|---|---|---|---|---|---|
< 50 | 10 | < 2 cm | 11 | N0 | 26 | Stage I | 8 | ER+ | 34 |
50–65 | 21 | 2–5 cm | 22 | N1 | 8 | Stage II | 23 | ER− | 6 |
> 65 | 16 | > 5 cm | 11 | N2 | 3 | Stage III | 13 | PR+ | 31 |
 |  | Unknown | 3 | N3 | 7 | Unknown | 3 | PR− | 9 |
 |  |  |  | Unknown | 3 |  |  | HER2+ | 11 |
 |  |  |  |  |  |  |  | HER2− | 28 |
 |  |  |  |  |  |  |  | Unknown | 7 |